X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5402) 5402
Publication (338) 338
Newsletter (131) 131
Book Review (57) 57
Magazine Article (39) 39
Newspaper Article (12) 12
Dissertation (9) 9
Book Chapter (6) 6
Trade Publication Article (6) 6
Conference Proceeding (3) 3
Book / eBook (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3481) 3481
salmeterol (3480) 3480
male (1958) 1958
albuterol - analogs & derivatives (1931) 1931
asthma (1904) 1904
salmeterol xinafoate (1891) 1891
respiratory system (1875) 1875
female (1853) 1853
asthma - drug therapy (1671) 1671
index medicus (1617) 1617
administration, inhalation (1462) 1462
middle aged (1382) 1382
adult (1295) 1295
fluticasone (1110) 1110
bronchodilator agents - therapeutic use (1102) 1102
albuterol - therapeutic use (1083) 1083
pulmonary disease, chronic obstructive - drug therapy (1051) 1051
aged (1039) 1039
bronchodilator agents - administration & dosage (987) 987
albuterol - administration & dosage (915) 915
double-blind method (900) 900
formoterol (886) 886
treatment outcome (885) 885
drug therapy, combination (842) 842
obstructive pulmonary-disease (842) 842
pharmacology & pharmacy (841) 841
copd (766) 766
fluticasone propionate (700) 700
drug therapy (695) 695
chronic obstructive pulmonary disease (689) 689
adolescent (651) 651
adrenergic beta-agonists - therapeutic use (651) 651
medicine, general & internal (635) 635
inhaled corticosteroids (598) 598
formoterol fumarate (589) 589
lung diseases, obstructive (589) 589
exacerbations (580) 580
drug combinations (567) 567
salbutamol (551) 551
corticosteroids (544) 544
tiotropium (536) 536
allergy (526) 526
budesonide (509) 509
asthma - physiopathology (502) 502
androstadienes - administration & dosage (491) 491
adrenergic beta-agonists - administration & dosage (488) 488
child (483) 483
pulmonary disease, chronic obstructive - physiopathology (465) 465
bronchodilator agents - adverse effects (436) 436
androstadienes - therapeutic use (435) 435
albuterol - pharmacology (434) 434
immunology (413) 413
adrenal cortex hormones - administration & dosage (400) 400
dose-response relationship, drug (394) 394
forced expiratory volume - drug effects (389) 389
efficacy (383) 383
albuterol - adverse effects (373) 373
therapy (373) 373
anti-asthmatic agents - therapeutic use (372) 372
cross-over studies (372) 372
quality of life (372) 372
double-blind (363) 363
research (360) 360
care and treatment (357) 357
forced expiratory volume (354) 354
ethanolamines - administration & dosage (346) 346
cardiac & cardiovascular systems (336) 336
time factors (336) 336
anti-asthmatic agents - administration & dosage (331) 331
albuterol (320) 320
dosage and administration (320) 320
tiotropium bromide (319) 319
adrenal cortex hormones - therapeutic use (316) 316
ethanolamines - therapeutic use (307) 307
adrenergic beta-agonists - pharmacology (305) 305
respiratory function tests (304) 304
safety (304) 304
animals (301) 301
severity of illness index (296) 296
randomized controlled trials as topic (295) 295
lung-function (294) 294
mortality (291) 291
children (286) 286
analysis (284) 284
drug administration schedule (277) 277
respiratory tract diseases (277) 277
inflammation (272) 272
fluticasone-salmeterol drug combination (270) 270
adrenergic beta-agonists - adverse effects (268) 268
aged, 80 and over (263) 263
pulmonary and respiratory medicine (263) 263
salmeterol/fluticasone propionate (261) 261
bronchodilator agents - pharmacology (258) 258
nebulizers and vaporizers (256) 256
pulmonary/respiratory (251) 251
persistent asthma (243) 243
risk factors (231) 231
combination (226) 226
antiasthmatic agents (223) 223
abridged index medicus (222) 222
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5215) 5215
German (109) 109
French (86) 86
Spanish (45) 45
Japanese (27) 27
Polish (27) 27
Italian (25) 25
Chinese (23) 23
Portuguese (11) 11
Danish (9) 9
Russian (8) 8
Romanian (4) 4
Dutch (3) 3
Czech (2) 2
Korean (2) 2
Norwegian (2) 2
Swedish (2) 2
Turkish (2) 2
Hebrew (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


LANCET, ISSN 0140-6736, 09/2016, Volume 388, Issue 10048, pp. 963 - 973
Background Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic... 
POPULATION | MEDICINE, GENERAL & INTERNAL | LUNG-FUNCTION | EXACERBATIONS | INDIVIDUAL COMPONENTS | TIOTROPIUM | FLUTICASONE PROPIONATE/SALMETEROL | GLYCOPYRRONIUM | COPD | SALMETEROL | SALMETEROL/FLUTICASONE
Journal Article
Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, ISSN 1098-3015, 10/2017, Volume 20, Issue 9, p. A889
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2016, Volume 374, Issue 23, pp. 2222 - 2234
Journal Article
Respirology, ISSN 1323-7799, 11/2017, Volume 22, Issue S3, pp. 178 - 178
Journal Article
Respirology, ISSN 1323-7799, 11/2017, Volume 22, Issue S3, pp. 176 - 177
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 9, p. CD006829
Background Both inhaled steroids (ICS) and long-acting beta(2)-agonists (LABA) are used in the management of chronic obstructive pulmonary disease (COPD). This... 
Adrenal Cortex Hormones [administration & dosage; adverse effects] | COST-EFFECTIVENESS | Adrenergic beta-Agonists [administration & dosage; adverse effects] | CLINICAL-TRIAL | Humans | FLUTICASONE PROPIONATE/SALMETEROL 250/50 | SALMETEROL/FLUTICASONE PROPIONATE | COPD EXACERBATIONS | LUNG-FUNCTION | RANDOMIZED CONTROLLED-TRIAL | Pneumonia [chemically induced] | Randomized Controlled Trials as Topic | SALMETEROL | Bronchodilator Agents [administration & dosage; adverse effects] | Pulmonary Disease, Chronic Obstructive [drug therapy; mortality] | MEDICINE, GENERAL & INTERNAL | METERED-DOSE INHALER | Quality of Life | Adult | Drug Therapy, Combination | 50 MU-G | Drug Combinations | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - mortality | Ethanolamines - adverse effects | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Fluticasone | Ethanolamines - administration & dosage | Pneumonia - chemically induced | Adrenergic beta-Agonists - administration & dosage | Albuterol - administration & dosage | Bronchodilator Agents - adverse effects | Adrenergic beta-Agonists - adverse effects | Salmeterol Xinafoate | Albuterol - analogs & derivatives | Adrenal Cortex Hormones - adverse effects | Drug Therapy, Combination - methods | Androstadienes - administration & dosage | Budesonide - adverse effects | Budesonide - administration & dosage | Androstadienes - adverse effects | Albuterol - adverse effects | Adrenal Cortex Hormones - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 06/2015, Volume 10, pp. 1015 - 1026
Background: The current Global initiative for chronic Obstructive Lung Disease (GOLD) treatment strategy recommends the use of one or more bronchodilators... 
Clinical trial | agonists | Long-acting muscarinic antagonist | Long-acting β | COPD | clinical trial | COST-EFFECTIVENESS | SAFETY | INHALED CORTICOSTEROIDS | SALMETEROL | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | PRIMARY-CARE | FLUTICASONE PROPIONATE | RESPIRATORY SYSTEM | DOUBLE-BLIND | TIOTROPIUM | long-acting beta-agonists | long-acting muscarinic antagonist | Bronchodilator Agents - therapeutic use | Indans - adverse effects | Spirometry | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Fluticasone-Salmeterol Drug Combination - therapeutic use | Pulmonary Disease, Chronic Obstructive - physiopathology | Muscarinic Antagonists - therapeutic use | Indans - therapeutic use | Recovery of Function | Fluticasone-Salmeterol Drug Combination - adverse effects | Forced Expiratory Volume | Quinolones - adverse effects | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Adult | Female | Surveys and Questionnaires | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glucocorticoids - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Double-Blind Method | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Glycopyrrolate - analogs & derivatives | Fluticasone-Salmeterol Drug Combination - administration & dosage | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Nebulizers and Vaporizers | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Drug therapy, Combination | Comparative analysis | Drug therapy | Methods | Bronchodilator agents
Journal Article
THORAX, ISSN 0040-6376, 06/2015, Volume 70, Issue 6, pp. 519 - 527
Background The optimal use of various therapeutic combinations for moderate/severe chronic obstructive pulmonary disease (COPD) is unclear. The GLISTEN trial... 
PROPIONATE | INDACATEROL | MODERATE | FORMOTEROL | OBSTRUCTIVE PULMONARY-DISEASE | EFFICACY | RESPIRATORY SYSTEM | COPD Pharmacology | TIOTROPIUM | FLUTICASONE PROPIONATE/SALMETEROL | COMBINATION | SALMETEROL
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 05/2017, Volume 195, Issue 9, pp. 1189 - 1197
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 2013, Volume 5, Issue 5, p. CD007891
Journal Article
Thorax, ISSN 0040-6376, 11/2006, Volume 61, Issue 11, pp. 940 - 944
Background: The homozygous presence of the arginine-16 variant of the β2 adrenoceptor gene ADRB2 reverses the benefits from the regular use of short acting β2... 
polymorphism | ADRB2 | children | salmeterol | Asthma
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2013, Volume 1, Issue 3, pp. 210 - 223
Journal Article